SARS-CoV-2 spike E484K mutation reduces antibody neutralisation
Open Access
- 7 April 2021
- journal article
- letter
- Published by Elsevier BV in The Lancet Microbe
- Vol. 2 (7), e283-e284
- https://doi.org/10.1016/s2666-5247(21)00068-9
Abstract
No abstract availableFunding Information
- JPB Foundation
- NIAID
- NCI
This publication has 4 references indexed in Scilit:
- mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variantsNature, 2021
- Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodiesCell Host & Microbe, 2021
- The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human seraPublished by Cold Spring Harbor Laboratory ,2021
- Escape from neutralizing antibodies by SARS-CoV-2 spike protein variantseLife, 2020